Farallon Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Farallon Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,900	Closed	-$234K	–	190
2024 Q1	$234K	Buy	+5,900	New	+$174K	﹤0.01%	141
2021 Q1	–	Sell	-200,000	Closed	-$2.52M	–	250
2020 Q4	$2.52M	Sell	200,000 -541,290	-73%	-$5.31M	0.02%	131
2020 Q3	$6.52M	Buy	+741,290	New	+$6.78M	0.05%	106

Farallon Capital Management's ALPN Position: Q2 2024 in Review

Farallon Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 5,900 shares — an estimated $234K sold.

Farallon Capital Management first reported a position in ALPN in Q3 2020 and held it in 3 quarters. The position peaked at $6.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Farallon Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Farallon Capital Management sold 5,900 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $234K.
Farallon Capital Management first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 3 quarters.
Farallon Capital Management's Alpine Immune Sciences Inc position peaked at $6.52M in Q3 2020.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.